2010 Annual Meeting

Session: Disease Therapies

This session welcomes contributions addressing the evaluation of therapeutic efficacy of drug delivery systems, stents, or tissue engineered scaffolds. The focus should be on their actual therapeutic potential. Contributions concerning mathematical modeling (or dosimetry) accompanying the above, or suggesting alternative strategies, are also welcome.

Chair

Manolis S. Tzanakakis, State University of New York at Buffalo

Co-Chair

Roger Harrison, University of Oklahoma